Usp44-flox Mouse
一般名
Usp44-flox
製品ID
S-CKO-10539
背景情報
C57BL/6JCya
系統ID
CKOCMP-327799-Usp44-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Usp44-flox Mouse(カタログ番号S-CKO-10539)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Usp44-flox
系統ID
CKOCMP-327799-Usp44-B6J-VA
遺伝子名
製品ID
S-CKO-10539
遺伝子別名
E430004F17Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 10
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000216224
NCBIトランスクリプトID
NM_001400981
ターゲット領域
Exon 2
有効領域の大きさ
~2.7 kb
遺伝子研究の概要
Usp44, a member of the ubiquitin-specific proteases (USPs) family, functions as a deubiquitinase. It participates in multiple biological processes by regulating the deubiquitination of various substrates, influencing pathways related to DNA repair, immune cell function, and cancer-related signaling [5].
In nasopharyngeal carcinoma, Usp44 is hypermethylated and down-regulated. It enhances radiotherapy sensitivity by recruiting and stabilizing TRIM25, which degrades Ku80 and inhibits non-homologous end-joining DNA repair. Knockout of TRIM25 reverses this radiotherapy sensitization effect, suggesting its role in tumor suppression [1].
In regulatory T cells (Tregs), Usp44 promotes Treg function during inflammation by preventing the degradation of FOXP3, an essential transcription factor for Tregs. Tregs lacking Usp44 are less effective in vitro and in vivo [2].
In hepatocellular carcinoma, Usp44 suppresses tumor progression by inhibiting the Hedgehog signaling pathway and PDL1 expression. It interacts with Itch, promoting Itch's deubiquitination and stabilization, leading to Gli1 degradation and inactivation of the pathway [3].
In neuroblastoma, high levels of Usp44 are associated with aggressive disease features. Depletion of the histone H2B ubiquitin ligase subunit RNF20, similar to Usp44 depletion, affects cell proliferation, migration, and invasion, indicating histone H2B as a potential target of Usp44 [4].
In breast cancer, hypermethylation of Usp44 leads to poor expression, and its overexpression suppresses cancer cell proliferation, migration, and invasion [6].
In cholangiocarcinoma, MAD2 interferes with the USP44/LIMA1 complex, promoting cancer progression [7].
In thyroid cancer, Usp44 inactivation accelerates tumor progression by inducing p21 ubiquitylation and degradation [8].
In oral squamous cell carcinoma, Usp44 acts as a tumor suppressor by stabilizing HEXIM1 protein and inhibiting cell proliferation and metastasis [9].
In conclusion, Usp44 plays crucial roles in various biological processes and disease conditions. Through gene knockout or other loss-of-function models in different cancers, it has been revealed that Usp44 can act as a tumor suppressor in many cases, influencing DNA repair, immune cell function, and cancer-related signaling pathways. Understanding Usp44's functions helps in exploring potential therapeutic targets for cancers such as nasopharyngeal carcinoma, hepatocellular carcinoma, and others.
References:
1. Chen, Yang, Zhao, Yin, Yang, Xiaojing, Ma, Jun, Liu, Na. 2022. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. In Nature communications, 13, 501. doi:10.1038/s41467-022-28158-2. https://pubmed.ncbi.nlm.nih.gov/35079021/
2. Yang, Jing, Wei, Ping, Barbi, Joseph, Pan, Fan, Li, Bin. 2020. The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation. In EMBO reports, 21, e50308. doi:10.15252/embr.202050308. https://pubmed.ncbi.nlm.nih.gov/32644293/
3. Chen, Sisi, Zhou, Binghai, Huang, Wei, Wang, Wei, Xie, Peiyi. 2023. The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression. In Cell death & disease, 14, 830. doi:10.1038/s41419-023-06358-y. https://pubmed.ncbi.nlm.nih.gov/38097536/
4. Ekstrom, Thomas L, Hussain, Sajjad, Bedekovics, Tibor, Johnsen, Steven A, Galardy, Paul J. . USP44 Overexpression Drives a MYC-Like Gene Expression Program in Neuroblastoma through Epigenetic Reprogramming. In Molecular cancer research : MCR, 22, 812-825. doi:10.1158/1541-7786.MCR-23-0454. https://pubmed.ncbi.nlm.nih.gov/38775808/
5. Lou, Yuming, Ye, Minfeng, Xu, Chaoyang, Tao, Feng. 2022. Insight into the physiological and pathological roles of USP44, a potential tumor target (Review). In Oncology letters, 24, 455. doi:10.3892/ol.2022.13575. https://pubmed.ncbi.nlm.nih.gov/36380875/
6. Chen, Xin, Wu, Xiaotang, Lei, Wen. 2020. USP44 hypermethylation promotes cell proliferation and metastasis in breast cancer. In Future oncology (London, England), 17, 279-289. doi:10.2217/fon-2020-0415. https://pubmed.ncbi.nlm.nih.gov/32956592/
7. Jiang, Wangjie, Yang, Xiao, Shi, Kuangheng, Li, Changxian, Li, Xiangcheng. 2023. MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex. In Oncogene, 42, 3344-3357. doi:10.1038/s41388-023-02849-6. https://pubmed.ncbi.nlm.nih.gov/37752233/
8. Liu, Yan, Yuan, Mengmeng, Xu, Xinxin, Yu, Wei, Ji, Meiju. 2024. USP44 inactivation accelerates the progression of thyroid cancer by inducing ubiquitylation and degradation of p21. In International journal of biological sciences, 20, 5223-5238. doi:10.7150/ijbs.99817. https://pubmed.ncbi.nlm.nih.gov/39430240/
9. Chen, Shuai, Wu, Kefan, Zong, Yingrui, Deng, Zhifen, Xia, Zongping. 2024. USP44 regulates HEXIM1 stability to inhibit tumorigenesis and metastasis of oral squamous cell carcinoma. In Biology direct, 19, 143. doi:10.1186/s13062-024-00573-z. https://pubmed.ncbi.nlm.nih.gov/39722007/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
